Previous Article | Next Article 
Journal of Clinical Microbiology, December 2001, p. 4554-4557, Vol. 39, No. 12
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.12.4554-4557.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Molecular Characterization of First Human
Bartonella Strain Isolated in Italy
Alessandra
Ciervo,1
Andrea
Petrucca,1
Simonetta
Ciarrocchi,1
Antonella
Pinto,1
Lucio
Bonazzi,2
Anna
Fabio,2
Enrico
Farnetti,2
Bruno B.
Chomel,3 and
Lorenzo
Ciceroni1,*
Department of Bacteriology and Medical
Mycology, Istituto Superiore di Sanità, 00161 Rome,1 and Department of Infectious
Diseases, Microbiology and Molecular Biology, Arcispedale S. Maria
Nuova, 42100 Reggio Emilia,2 Italy,
and Department of Population Health and Reproduction, School
of Veterinary Medicine, University of California, Davis, California
956163
Received 28 June 2001/Returned for modification 6 August
2001/Accepted 13 September 2001
 |
ABSTRACT |
The aim of this study was to characterize a Bartonella
strain (BA-1) isolated from a blood culture of an Italian, human
immunodeficiency virus-positive patient with bacillary angiomatosis. We
analyzed the isolate using molecular biology methods such as whole-cell fatty acid analysis, PCR-restriction fragment length polymorphism analysis, type-specific 16S rRNA PCRs, sequence analysis of the 16S
rRNA, pulsed-field gel electrophoresis, and arbitrarily primed PCR. The
BA-1 isolate turned out to be a Bartonella quintana strain, similar but not identical to B. quintana Oklahoma, which
was used as a control strain.
 |
TEXT |
Among the 14 species now included in
the genus Bartonella, at least 7 are human pathogens.
Bartonella henselae, the most common cause of cat scratch
disease, and B. quintana, the trench fever bacillus, are
related species that can also cause a common spectrum of clinical
diseases such as bacillary angiomatosis (BA), peliosis hepatis,
relapsing bacteremia with fever, chronic lymphadenopathy, and
endocarditis. The isolation of Bartonella strains is not a straightforward task but is extremely important for both etiological diagnosis and genetic investigation of the isolates (21).
We report molecular characterization of BA-1, a Bartonella
strain isolated from a patient with BA.
In June 1997, a 37-year-old male who was a heroin user and had been
infected with human immunodeficiency virus (HIV) since 1985 was
admitted to the Arcispedale S. Maria Nuova (Reggio Emilia, Italy),
presenting with high recurrent fever and multiple nodular papules over
his whole integument. Histologic examination of a skin biopsy specimen
showed features typical of BA. Warthin-Starry staining revealed a
cluster of small bacilli. Echography showed that the liver was
involved. Patient serum yielded a high diagnostic titer (1:512) when it
was tested in an indirect immunofluorescence assay using B. henselae as an antigen. Three blood samples showed bacterial
growth after 35 days of incubation in BACTEC bottles (BACTEC NR730;
Becton Dickinson, Cockeysville, Md.). The organisms were subcultured in
5% CO2 at 37°C on brain heart infusion agar (BBL, Becton
Dickinson) plates supplemented with 5% rabbit blood. After 4 to 7 days, 0.5- to 2-mm-diameter colonies were visible. The isolated
organisms were small, gram-negative, oxidase- and catalase-negative,
nonfermentative, nonmotile rods.
In this study, the following strains of three different species of
Bartonella were used as positive controls: B. henselae Houston-1 (ATCC 49882, type I strain); B. henselae 269608 (type II strain) isolated at the University of
California, Davis, from the blood of a 20-year-old pet cat from
northern California; B. quintana Oklahoma, a blood culture
strain isolated from an HIV-positive patient in Oklahoma; and B. clarridgeiae (ATCC 51734). B. henselae Pavia-1,
isolated from a cat in Italy, was also included in the analysis
(9).
Fatty acid methyl ester derivatives were prepared for gas
chromatographic analysis by using the following four-phase procedure: saponification, methylation, extraction, and a base wash as described elsewhere (5). The fatty acid composition observed for the new isolate was characterized by a relatively simple profile: large
amounts of C16:0 (hexadecanoic acid) (27.5%),
C18:1
7 (cis-11-octadecenoic acid) (39.5%),
and C18:0 (octadecenoic acid) (31.8%) and minor amounts of
C18:2
6 (cis-9,12-octadecadienoic acid)
(traces) and C18:1
9 (cis-9-octadecanoic acid)
(1.2%). The high similarity between the whole-cell fatty acid (CFA)
composition of BA-1 and those of B. quintana, B. henselae, and B. clarridgeiae (data not shown)
identified the isolate as a member of the genus Bartonella
but did not allow identification of the species.
The primers BhCS.781p (5'-GGGGACCAGCTCATGGTGG-3') and
BhCS.1137n (5'-AATGCAAAAAGAACAGTAAACA-3') were used to
amplify a fragment of the Bartonella citrate synthase gene
by PCR as previously described (15). The amplicons (379 bp) were subjected to restriction fragment length polymorphism (RFLP)
analysis with TaqI restriction endonuclease (Fig.
1). We found identical profiles for
B. henselae Houston-1, B. henselae 269608, and
B. henselae Pavia-1 (bands of 171, 137, and 71 bp). Patterns
were also identical in B. quintana Oklahoma and BA-1 (bands
of 316 and 63 bp). The profile of the B. clarridgeiae reference strain was different from those of B. henselae and
B. quintana.

View larger version (110K):
[in this window]
[in a new window]
|
FIG. 1.
PCR-RFLP analysis with TaqI restriction
enzyme of the citrate synthase gene. Lanes: M, molecular marker VIII
(Boehringer Mannheim, Mannheim, Germany); 1, B. henselae
Houston-1 (ATCC49882, type I strain); 2, B. henselae
269608 (type II strain); 3, B. henselae Pavia-1; 4, BA-1; 5, B. quintana Oklahoma; 6, B. clarridgeiae (ATCC
51734). Values at the left are molecular sizes (in base pairs).
|
|
Amplification of the 16S rRNA gene with the universal primer 16SF
[5'-AGAGTTTGATCCTGG(CT)TCAG-3'] and with either of the
type-specific primers BH1 (5'-CCGATAAATCTTTCTCCCTAA-3') and
BH2 (5'-CCGATAAATCTTTCTCCAAAT-3') was carried out as
described elsewhere (1, 22). Two annealing temperatures
were applied for PCR amplification: 56 and 58°C. As expected, the
B. henselae Houston-1 and B. henselae Pavia-1 isolates yielded a PCR product in the type I PCR while B. henselae 269608 was positive in the type II PCR. Surprisingly, the
BA-1 isolate and B. clarridgeiae yielded a PCR product when
the primers specific for type I were used. Similarly to strain B. henselae Houston-1 and the reference strain of B. clarridgeiae, the new isolate was positive in the type I PCR when
the DNA was amplified at 58°C. In contrast, B. quintana
Oklahoma DNA was negative in both PCRs at both annealing temperatures
(Fig. 2).

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 2.
Type-specific 16S rRNA PCRs. PCR products were obtained
at an annealing temperature of 58°C with primers BH1 (A) and BH2 (B).
Lanes: M, molecular size marker VIII (Boehringer Mannheim); 1, B. henselae Houston-1 (ATCC 49882, type I strain); 2, B. henselae 269608 (type II strain); 3, B. henselae
Pavia-1; 4, BA-1; 5, B. quintana Oklahoma; 6, B. clarridgeiae (ATCC 51734). The value at the left is a molecular
size (in base pairs).
|
|
The 16S rRNA of the BA-1 isolate was amplified by using two universal
eubacterial primers, 27f (5'-GAGAGTTTGATCCTGGCTCAG-3') and
1495r (5'-CTACGGCTACCTTGTTACGA-3') (24). The
amplicon, a 1,455-bp product, was cloned in the pGEM-T easy vector
(Promega, Madison, Wis.). Sequencing was performed with a commercial T7 sequencing kit (Pharmacia Biotech) with M13 forward and reverse primers, and results were analyzed on a Pharmacia Biotech
ALFExpress automated DNA sequencer. The sequence obtained
was compared to others by using the BLAST search tool
(http://www.ncbi.n/m.nib.gov/BLAST/). The 16S rRNA gene sequence
obtained (GenBank accession number AJ250247) revealed a 99% identity
with the sequence described for B. quintana Fuller (GenBank
accession number M11927), confirming the identification of BA-1 as
B. quintana.
To further characterize the BA-1 isolate, pulsed-field gel
electrophoresis (PFGE) and arbitrarily primed PCR (AP-PCR) were carried
out. Genomic DNAs were prepared according to the procedure described by
Maurin et al. (14) and were digested with SmaI (Fig. 3A). Among the five strains used as
controls, B. quintana Oklahoma and B. clarridgeiae were easily distinguishable from one another and from
the three B. henselae isolates by visual inspection. In
contrast, very similar restriction patterns were obtained for B. henselae Houston-1, B. henselae 269608, and B. henselae Pavia-1. Very similar restriction patterns were also found for B. quintana Oklahoma and the BA-1 isolate. The
restriction pattern of BA-1 showed 23 bands, 20 of which were common to
the pattern found for B. quintana Oklahoma. With the Dice
coefficient, the patterns of these two strains could be discriminated,
having a cutoff of 94% similarity.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 3.
(A) PFGE analysis with SmaI and
dendrogram of fingerprints determined by the Dice coefficient. The
digestion products were separated at 190 V for 19 h in 1%
agarose-0.25× Tris-borate-EDTA with a pulse time increasing from 3 to
10 s. (B) AP-PCR and dendogram of fingerprints determined by the
Dice coefficient. Lanes: 1, B. henselae Houston-1 (ATCC
49882, type I strain); 2, B. henselae 269608 (type II
strain); 3, B. henselae Pavia-1; 4, B. clarridgeiae (ATCC 51734); 5, BA-1; 6, B. quintana
Oklahoma.
|
|
AP-PCR was performed with the core sequence of phage M13
(5'-GAGGGTGGCGGTTCT-3') as described previously (11,
22). The fingerprints were analyzed with GelCompar software,
Windows version 4.0 (Applied Maths, Kortrijk, Belgium) (Fig. 3B). The
patterns produced were compared by using the Dice coefficient. For
clustering, the unweighted pair group method with arithmetic means was
used. Three groups were identified on the basis of AP-PCR fingerprints. Group I consisted solely of B. henselae strains. Group II
contained B. quintana Oklahoma and the new isolate. Group
III contained only the reference strain of B. clarridgeiae.
The B. quintana Oklahoma and BA-1 isolates had a similarity
level of 80% in the dendrogram and could thus be differentiated.
For further in-depth molecular studies, six biological methods were
used to characterize the BA-1 isolate. All methods applied were found
to be useful. The phenotypic characterization by CFA allowed for the
identification of the isolate at the genus level, while the genotypic
characterization by PCR-RFLP analysis of a fragment of the citrate
synthase gene discriminated among B. henselae, B. quintana, and B. clarridgeiae and identified the BA-1
isolate as B. quintana. Amplification and sequencing of the
complete 16S rRNA gene were also performed for the BA-1 isolate. The
sequence obtained was almost identical to that of B. quintana Fuller.
Surprisingly, the type-specific PCRs with BH1 and BH2 were not as
strictly species specific for B. henselae as expected. In fact, with the exception of B. quintana Oklahoma, all
strains, including the type strain of B. clarridgeiae and
the BA-1 isolate, yielded PCR products with these primers.
Compared with CFA and PCR-RFLP analysis, AP-PCR and PFGE showed a
higher discriminatory power. As expected, both methods proved to be
suitable for strain differentiation at the species level and sensitive
in detecting minor differences among strains of the same
Bartonella genus and species. Strains BA-1 and B. quintana Oklahoma produced similar but not identical PFGE and
AP-PCR profiles. The genetic variation of B. quintana
isolates was less pronounced than the variation of the three
B. henselae isolates. The level of similarity among AP-PCR
and PFGE fingerprints for B. quintana Oklahoma and BA-1
suggests that these two strains derive from different clones.
B. quintana is an emerging human pathogen that causes a wide
spectrum of clinical diseases (urban trench fever, BA, peliosis hepatis, peliosis spleniitis, lymphadenopathy, and endocarditis) in both immunocompetent and immunocompromised hosts (16).
Little is known about the geographical distribution of B. quintana in Europe. Although many B. quintana strains
have been isolated in France (3, 4, 7, 8, 13, 14, 17, 18),
the organism has rarely been recovered in other European countries
(10, 23). In 1995, Drancourt et al. (7)
reported the isolation of B. quintana from three homeless
patients with endocarditis in France. Brouqui et al. (3)
investigated the prevalence of Bartonella species in blood
samples from all of the homeless people who availed themselves of the
emergency department of the University Hospital, Marseille,
France, between October 1993 and October 1994. For 10 out of 71 homeless patients (14%), blood cultures were positive for B. quintana, and in 21 of the patients (30%), high titers of
antibodies against this organism were detected. No such epidemiological study has yet been carried out in Italy.
In conclusion, our study has shown that (i) B. quintana is
an etiological agent of BA in Italy, (ii) the BA-1 isolate can be
discerned from B. quintana Oklahoma, and (iii) contrarily to what we had expected, the type-specific primers BH1 and BH2 produced species-specific PCR products not only for B. henselae but
for B. clarridgeiae and B. quintana BA-1 as well.
Our results suggest that, in addition to B. henselae,
B. quintana should be included as an antigen in the
immunofluorescence test for the serological diagnosis of some
Bartonella infections, even in those countries where trench
fever and other B. quintana infections are not known to
occur. Further investigations, however, are necessary (i) to determine
the incidence of B. quintana infections, (ii) to establish whether more than one B. quintana clone exists in Italy, and
(iii) to assess the degree of cross-reactivity between our isolate and the B. quintana Fuller strain. Urban trench fever has
emerged among homeless persons in France (2), homeless,
alcoholic, HIV-negative persons in Seattle, Wash. (12),
and intravenous-drug abusers in Baltimore, Md. (6), and it
has reemerged in Burundi after an absence of 12 years
(19). B. quintana has been molecularly demonstrated to exist in body lice collected from homeless persons in
Russia (20). All of this emphasizes the need for
establishing regional surveillance laboratories for the detection and
characterization of fastidious microbial pathogens as well as active
surveillance programs. Outbreaks of louse-borne infections can occur in
populations that live under squalid conditions (e.g., refugees or those
left homeless as a consequence of war or natural disaster), where louse infestations are frequent. Even if the factors leading to outbreaks remain poorly understood, all methods for reducing louse infestation and avoiding crowding under poor hygienic conditions have been advocated as strategies for the prevention of B. quintana infection.
 |
ACKNOWLEDGMENTS |
We thank M. Carla Liberto for the B. quintana Oklahoma strain.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Istituto
Superiore di Sanità, Department of Bacteriology and Medical
Mycology, Viale Regina Elena 299, 00161 Rome, Italy. Phone: (39)
6-49902741. Fax: (39) 6-49902934 or (39) 6-49387112. E-mail:
ciceroni{at}iss.it.
 |
REFERENCES |
| 1.
|
Bergmans, A. M. C.,
J. F. P. Schellekens,
J. D. A. van Embden, and L. M. Schouls.
1996.
Predominance of two Bartonella henselae variants among cat-scratch disease patients in The Netherlands.
J. Clin. Microbiol.
34:254-260[Abstract].
|
| 2.
|
Brouqui, P.,
P. Houpikian,
H. Tissot-Dupont,
P. Toubiana,
Y. Obadia,
V. Lafay, and D. Raoult.
1996.
Survey of the seroprevalence of Bartonella quintana in homeless people.
Clin. Infect. Dis.
23:756-759[Medline].
|
| 3.
|
Brouqui, P.,
B. La Scola,
V. Roux, and D. Raoult.
1999.
Chronic Bartonella quintana bacteremia in homeless patients.
N. Engl. J. Med.
340:184-189[Abstract/Free Full Text].
|
| 4.
|
Bruneel, F.,
J. D'Estanque,
P. E. Fournier,
G. Arlet,
M. Thuong,
M. Wolff,
J. P. Bedos,
S. Lariven, and B. Regnier.
1998.
Isolated right-sided Bartonella quintana endocarditis in an immunocompetent adult.
Scand. J. Infect. Dis.
30:424-425[CrossRef][Medline].
|
| 5.
|
Cacciapuoti, B.,
L. Ciceroni, and D. Attard Barbini.
1991.
Fatty acid profiles, a chemotaxonomic key for the classification of strains of the family Leptospiraceae.
Int. J. Syst. Bacteriol.
41:295-300[Abstract/Free Full Text].
|
| 6.
|
Comer, J. A.,
C. Flynn,
R. L. Regnery,
D. Vlahov, and J. E. Childs.
1996.
Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md.
Arch. Intern. Med.
156:2491-2495[Abstract].
|
| 7.
|
Drancourt, M.,
J. L. Mainardi,
P. Brouqui,
F. Vandenesch,
A. Carta,
F. Lehnert,
J. Etienne,
F. Goldstein,
J. Acar, and D. Raoult.
1995.
Bartonella (Rochalimaea) quintana endocarditis in three homeless men.
N. Engl. J. Med.
332:419-423[Abstract/Free Full Text].
|
| 8.
|
Drancourt, M.,
V. Moal,
P. Brunet,
B. Dussol,
Y. Berland, and D. Raoult.
1996.
Bartonella (Rochalimaea) quintana infection in a seronegative hemodialyzed patient.
J. Clin. Microbiol.
34:1158-1160[Abstract].
|
| 9.
|
Fabbi, M.,
B. B. Chomel,
L. Guicciardi,
R. W. Kasten,
P. Marone,
S. Magnino,
R. Bragoni,
E. Carretto, and S. Taschini.
1999.
Isolamento di Bartonella henselae biotipo 1 e biotipo 2 da gatti in un paziente con CSD complicata da granulomatosi epato-splenica.
Microbiol. Med.
14:111-112.
|
| 10.
|
Goldenberger, D.,
T. Schimdheini, and M. Altwegg.
1997.
Detection of Bartonella henselae and Bartonella quintana by a simple and rapid procedure using broad-range PCR amplification and direct single-strand sequencing of part of the 16S rRNA gene.
Clin. Microbiol. Infect.
3:240-245[Medline].
|
| 11.
|
Gräser, Y.,
I. Klare,
E. Halle,
R. Gantenberg,
P. Buchholz,
H. D. Jacobi,
W. Presber, and G. Schönian.
1993.
Epidemiological study of an Acinetobacter baumannii outbreak by using polymerase chain reaction fingerprinting.
J. Clin. Microbiol.
31:2417-2420[Abstract/Free Full Text].
|
| 12.
|
Jackson, L. A.,
D. H. Spach,
D. A. Kippen,
N. K. Sugg,
R. L. Regnery,
M. H. Sayers, and W. E. Stamm.
1996.
Seroprevalence to Bartonella quintana among patients at a community clinic in downtown Seattle.
J. Infect. Dis.
173:1023-1026[Medline].
|
| 13.
|
La Scola, B., and D. Raoult.
1999.
Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998).
J. Clin. Microbiol.
37:1899-1905[Abstract/Free Full Text].
|
| 14.
|
Maurin, M.,
V. Roux,
A. Stein,
F. Ferrier,
R. Viraben, and D. Raoult.
1994.
Isolation and characterization by immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, Western blot, restriction fragment length polymorphism-PCR, 16S rRNA gene sequencing, and pulsed-field gel electrophoresis of Rochalimaea quintana from a patient with bacillary angiomatosis.
J. Clin. Microbiol.
32:1166-1171[Abstract/Free Full Text].
|
| 15.
|
Norman, A. F.,
R. Regnery,
P. Jameson,
C. Greene, and D. C. Krause.
1995.
Differentiation of Bartonella-like isolates at the species level by PCR-restriction fragment length polymorphism in the citrate synthase gene.
J. Clin. Microbiol.
33:1797-1803[Abstract].
|
| 16.
|
Ohl, M. E., and D. H. Spach.
2000.
Bartonella quintana and urban trench fever.
Clin. Infect. Dis.
31:131-135[CrossRef][Medline].
|
| 17.
|
Raoult, D.,
M. Drancourt,
A. Carta, and J. A. Gastaut.
1994.
Bartonella (Rochalimae) quintana isolation in patient with chronic adenopathy, lymphopenia, and a cat.
Lancet
343:977[CrossRef][Medline].
|
| 18.
|
Raoult, D.,
P. E. Fournier,
M. Drancourt,
T. J. Marrie,
J. Etienne,
J. Cosserat,
P. Cacoub,
Y. Poinsignon,
P. Leclerq, and A. M. Sefton.
1996.
Diagnosis of 22 new cases of Bartonella endocarditis.
Ann. Intern. Med.
125:646-652[Abstract/Free Full Text].
|
| 19.
|
Raoult, D.,
J. B. Ndihokubwayo,
H. Tissot-Dupont,
V. Roux,
B. Faugere,
R. Abegbinni, and R. J. Birtles.
1998.
Outbreak of epidemic typhus associated with trench fever in Burundi.
Lancet
352:353-358[CrossRef][Medline].
|
| 20.
|
Rydkina, E. B.,
V. Roux,
E. M. Gagua,
A. B. Predtechenski,
I. V. Tarasevich, and D. Raoult.
1999.
Bartonella quintana in body lice collected from homeless persons in Russia.
Emerg. Infect. Dis.
5:176-178[Medline].
|
| 21.
|
Sander, A.
1998.
Microbiological diagnosis of Bartonella species and Afipia felis, p. 98-112.
In
A. Schmidt (ed.), Bartonella and Afipia species emphasizing Bartonella henselae, vol. 1. Karger, Basel, Switzerland.
|
| 22.
|
Sander, A.,
M. Ruess,
S. Bereswill,
M. Schuppler, and B. Steinbrueckner.
1998.
Comparison of different DNA fingerprinting techniques for molecular typing of Bartonella henselae isolates.
J. Clin. Microbiol.
36:2973-2981[Abstract/Free Full Text].
|
| 23.
|
Schmidt, H. U.,
T. Kaliebe,
J. Poppinger,
C. Buhler, and A. Sander.
1996.
Isolation of Bartonella quintana from an HIV-positive patient with bacillary angiomatosis.
Eur. J. Clin. Microbiol. Infect. Dis.
15:736-741[CrossRef][Medline].
|
| 24.
|
Tabacchioni, S.,
P. Visca,
L. Chiarini,
A. Bevivino,
C. Di Serio,
S. Fancelli, and R. Fani.
1995.
Molecular characterization of clinical and environmental isolates of Burkholderia cepacia.
Res. Microbiol.
146:531-542[Medline].
|
Journal of Clinical Microbiology, December 2001, p. 4554-4557, Vol. 39, No. 12
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.12.4554-4557.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.